DIAGNOS Inc. (CVE:ADK – Get Free Report) Director Michael Braeuel purchased 53,571 shares of DIAGNOS stock in a transaction that occurred on Thursday, July 30th. The stock was purchased at an average price of C$0.28 per share, with a total value of C$14,999.88. Following the completion of the purchase, the director directly owned 2,148,880 shares in the company, valued at C$601,686.40. This trade represents a 2.56% increase in their ownership of the stock.
Michael Braeuel also recently made the following trade(s):
- On Thursday, July 30th, Michael Braeuel acquired 50,000 shares of DIAGNOS stock. The stock was purchased at an average cost of C$0.28 per share, for a total transaction of C$14,000.00.
- On Thursday, July 30th, Michael Braeuel acquired 25,000 shares of DIAGNOS stock. The shares were purchased at an average price of C$0.28 per share, for a total transaction of C$7,000.00.
DIAGNOS Stock Performance
Shares of ADK traded up C$0.01 during midday trading on Friday, reaching C$0.28. 35,149 shares of the stock were exchanged, compared to its average volume of 210,613. DIAGNOS Inc. has a twelve month low of C$0.17 and a twelve month high of C$0.41. The company has a quick ratio of 0.68, a current ratio of 1.49 and a debt-to-equity ratio of 204.05. The company has a market cap of C$33.72 million, a P/E ratio of -7.00 and a beta of -0.12. The stock’s 50 day simple moving average is C$0.23 and its 200 day simple moving average is C$0.26.
About DIAGNOS
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.
Read More
- Five stocks we like better than DIAGNOS
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.
